[_a]
aDepartment of Nephrology, Hospital Infanta Leonor, Madrid, Spain
[_b]
bDepartment of Nephrology, IIS-Fundación Jiménez Díaz, UAM/FJD, Madrid, Spain
[_c]
cCIBERDEM, Madrid, Spain
[_d]
dREDINREN, Madrid, Spain
*Sebastian Mas Fontao, Department of Vascular, Renal and Diabetes Research Laboratory,
Instituto de Investigación Sanitaria Fundacion Jimenez Diaz, University/Hospital Universidad
Autonoma de Madrid, Av. Reyes Católicos 2, ES–28040 Madrid (Spain), E-Mail smas@fjd.es
License:
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives
4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes
as well as any distribution of modified material requires written permission. Drug
Dosage: The authors and the publisher have exerted every effort to ensure that drug
selection and dosage set forth in this text are in accord with current recommendations
and practice at the time of publication. However, in view of ongoing research, changes
in government regulations, and the constant flow of information relating to drug therapy
and drug reactions, the reader is urged to check the package insert for each drug
for any changes in indications and dosage and for added warnings and precautions.
This is particularly important when the recommended agent is a new and/or infrequently
employed drug. Disclaimer: The statements, opinions and data contained in this publication
are solely those of the individual authors and contributors and not of the publishers
and the editor(s). The appearance of advertisements or/and product references in the
publication is not a warranty, endorsement, or approval of the products or services
advertised or of their effectiveness, quality or safety. The publisher and the editor(s)
disclaim responsibility for any injury to persons or property resulting from any ideas,
methods, instructions or products referred to in the content or advertisements.